Concepts (93)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Patient Readmission | 4 | 2021 | 1543 | 0.57 | Why? |
| Internal Medicine | 3 | 2021 | 557 | 0.31 | Why? |
| Patient Discharge | 4 | 2018 | 5696 | 0.27 | Why? |
| Turkey | 8 | 2021 | 3937 | 0.26 | Why? |
| Levamisole | 1 | 2020 | 24 | 0.21 | Why? |
| Psychometrics | 1 | 2017 | 1269 | 0.20 | Why? |
| Pyrazines | 1 | 2021 | 1783 | 0.20 | Why? |
| Amides | 1 | 2021 | 1864 | 0.20 | Why? |
| Tryptophan | 1 | 2021 | 218 | 0.19 | Why? |
| Perception | 2 | 2018 | 2827 | 0.19 | Why? |
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2020 | 1510 | 0.18 | Why? |
| Heparin | 1 | 2020 | 2600 | 0.17 | Why? |
| Azithromycin | 1 | 2021 | 3943 | 0.15 | Why? |
| Nebivolol | 1 | 2014 | 12 | 0.14 | Why? |
| Forecasting | 1 | 2018 | 4492 | 0.13 | Why? |
| Angiotensin Receptor Antagonists | 1 | 2020 | 3892 | 0.13 | Why? |
| Tetrazoles | 1 | 2014 | 262 | 0.11 | Why? |
| Physicians | 2 | 2021 | 4214 | 0.11 | Why? |
| Cytochrome P-450 Enzyme System | 1 | 2020 | 144 | 0.10 | Why? |
| Anti-Bacterial Agents | 1 | 2021 | 10083 | 0.09 | Why? |
| Survivors | 1 | 2021 | 2619 | 0.09 | Why? |
| Imidazoles | 1 | 2014 | 631 | 0.09 | Why? |
| Diarrhea | 1 | 2020 | 2743 | 0.09 | Why? |
| Health Knowledge, Attitudes, Practice | 2 | 2018 | 8811 | 0.09 | Why? |
| Translating | 1 | 2017 | 80 | 0.09 | Why? |
| Early Medical Intervention | 1 | 2021 | 487 | 0.09 | Why? |
| Antiviral Agents | 2 | 2021 | 41703 | 0.08 | Why? |
| Hydroxychloroquine | 1 | 2021 | 12447 | 0.08 | Why? |
| Length of Stay | 3 | 2021 | 11042 | 0.08 | Why? |
| Drug Therapy, Combination | 2 | 2021 | 7268 | 0.08 | Why? |
| Behavior | 1 | 2018 | 252 | 0.08 | Why? |
| Factor Analysis, Statistical | 1 | 2017 | 538 | 0.07 | Why? |
| Antiretroviral Therapy, Highly Active | 1 | 2020 | 952 | 0.07 | Why? |
| HIV Infections | 1 | 2020 | 11620 | 0.07 | Why? |
| Immunologic Factors | 1 | 2020 | 4206 | 0.07 | Why? |
| Logistic Models | 2 | 2018 | 9089 | 0.06 | Why? |
| Emergency Service, Hospital | 1 | 2018 | 14232 | 0.06 | Why? |
| Reproducibility of Results | 2 | 2021 | 11304 | 0.06 | Why? |
| Drug Interactions | 1 | 2020 | 1653 | 0.06 | Why? |
| Hospitals, University | 2 | 2021 | 4173 | 0.06 | Why? |
| Prospective Studies | 4 | 2021 | 43301 | 0.06 | Why? |
| Antihypertensive Agents | 1 | 2014 | 1962 | 0.06 | Why? |
| Vaccination | 1 | 2017 | 19050 | 0.06 | Why? |
| Algorithms | 1 | 2018 | 7346 | 0.05 | Why? |
| Hypertension | 2 | 2020 | 8895 | 0.05 | Why? |
| Adult | 9 | 2021 | 244371 | 0.05 | Why? |
| Demography | 1 | 2017 | 1660 | 0.05 | Why? |
| Aged, 80 and over | 5 | 2021 | 88759 | 0.05 | Why? |
| Hospitalization | 1 | 2021 | 54280 | 0.05 | Why? |
| Risk Assessment | 2 | 2018 | 25439 | 0.05 | Why? |
| Middle Aged | 9 | 2021 | 270681 | 0.05 | Why? |
| Humans | 15 | 2021 | 930598 | 0.04 | Why? |
| Male | 10 | 2021 | 367725 | 0.04 | Why? |
| Diabetes Complications | 1 | 2020 | 2358 | 0.04 | Why? |
| Anxiety | 2 | 2021 | 17311 | 0.04 | Why? |
| Sex Factors | 2 | 2020 | 11014 | 0.04 | Why? |
| Female | 9 | 2021 | 380317 | 0.04 | Why? |
| Tertiary Healthcare | 1 | 2021 | 616 | 0.04 | Why? |
| ROC Curve | 1 | 2018 | 6024 | 0.04 | Why? |
| Treatment Outcome | 3 | 2021 | 51732 | 0.04 | Why? |
| Quality Indicators, Health Care | 1 | 2021 | 580 | 0.04 | Why? |
| Aged | 6 | 2021 | 215776 | 0.04 | Why? |
| Young Adult | 3 | 2021 | 93724 | 0.04 | Why? |
| Mental Health | 1 | 2020 | 15770 | 0.03 | Why? |
| Cross-Sectional Studies | 3 | 2021 | 53120 | 0.03 | Why? |
| Plasminogen Activator Inhibitor 1 | 1 | 2014 | 162 | 0.03 | Why? |
| Risk Factors | 3 | 2020 | 71621 | 0.03 | Why? |
| Tertiary Care Centers | 2 | 2021 | 8248 | 0.03 | Why? |
| Patient Safety | 1 | 2017 | 4885 | 0.03 | Why? |
| Vasodilation | 1 | 2014 | 258 | 0.03 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.03 | Why? |
| Educational Status | 1 | 2018 | 1451 | 0.03 | Why? |
| Socioeconomic Factors | 1 | 2018 | 8495 | 0.03 | Why? |
| Adaptation, Psychological | 1 | 2018 | 4996 | 0.02 | Why? |
| Comorbidity | 2 | 2018 | 34796 | 0.02 | Why? |
| Vaccines | 1 | 2017 | 3692 | 0.02 | Why? |
| Pneumonia, Viral | 2 | 2020 | 243684 | 0.02 | Why? |
| Anxiety Disorders | 1 | 2020 | 2290 | 0.02 | Why? |
| Coronavirus Infections | 2 | 2020 | 253789 | 0.02 | Why? |
| Nitric Oxide | 1 | 2014 | 769 | 0.02 | Why? |
| Surveys and Questionnaires | 2 | 2020 | 43792 | 0.02 | Why? |
| Age Factors | 1 | 2018 | 21039 | 0.02 | Why? |
| Family | 1 | 2020 | 2909 | 0.02 | Why? |
| Intensive Care Units | 1 | 2021 | 29594 | 0.02 | Why? |
| Severity of Illness Index | 1 | 2021 | 48226 | 0.02 | Why? |
| Blood Pressure | 1 | 2014 | 2198 | 0.02 | Why? |
| C-Reactive Protein | 1 | 2014 | 7972 | 0.01 | Why? |
| Stress, Psychological | 1 | 2020 | 10231 | 0.01 | Why? |
| Health Personnel | 1 | 2017 | 29646 | 0.01 | Why? |
| Pandemics | 4 | 2021 | 389249 | 0.01 | Why? |
| Cohort Studies | 1 | 2018 | 36005 | 0.01 | Why? |
| Neoplasms | 1 | 2018 | 17251 | 0.01 | Why? |
| Adolescent | 1 | 2018 | 86841 | 0.01 | Why? |
Güven's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(93)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(42)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_